Q2 FY27 — 3 Nov 2026
Krsnaa Diagnostics Limited Q2 FY27
Krsnaa Diagnostics delivered strong operational revenue growth of 32% YoY in Q2 FY27 to ₹271 crores and crossed ₹500 crores in half-yearly revenue for the first time (₹507 crores in H1 FY27). Profitability saw slight margin compression to 27% EBITDA margin and PAT of ₹25 crores due to upfront operating costs and manpower scaling for new projects, notably Rajasthan. A central focus for investors was the elevated receivables balance of ₹470 crores, against which management expects collections of approximately ₹200 crores in Q3 FY27 as state disbursements resume.
Read the full call






